VENTRIKELUNTERSTÜTZUNGSVORRICHTUNG

Patent europeic · EP4039321 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4039321
Numer da la dumonda
EP22155936
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
10-01-2019
Publitgà
10-08-2022
Concedì
25-03-2026
La protecziun finescha il pli tard
09-01-2039
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61M 60/237 (2021.01)
A61M 60/13 (2021.01)
A61M 60/414 (2021.01)
A61M 60/808 (2021.01)
A61M 60/812 (2021.01)
A61M 60/816 (2021.01)
A61M 60/833 (2021.01)
Prioritad
US 201862615538 P 10.01.2018
US 201862665718 P 02.05.2018
US 201862681868 P 07.06.2018
US 201862727605 P 06.09.2018
Derivà da
EP19704873
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-03-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 25.03.2026

Partidas

Possessur

Magenta Medical Ltd.

Haofeh 1, 6092000 Kadima, IL

Inventur

TUVAL, Yosi

4050426 Even, Yehuda, IL

SOHN, Zev

4485500 Karnei, Shomron, IL

SCHWAMMENTHAL, Ehud

4341103 Raanana, IL

LUBINSKY, Gad

4069600, Ein Vered, IL

GLOZMAN, Daniel

Kfar Yona 4034723, IL

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.